Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.5720
-0.0210 (-3.54%)
Oct 31, 2025, 11:59 AM EDT - Market open
VRAX's stock price has decreased by -74.17% in the past year and price targets may not have had time to catch up.

Virax Biolabs Group Analyst Ratings

Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$3.00
Upside
+424.48%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$3
Strong BuyInitiates$3+424.48%Mar 31, 2025